XML 45 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations - Additional Information (Detail) (USD $)
12 Months Ended 0 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
May 31, 2014
Minimum
May 31, 2014
Maximum
Jul. 01, 2013
SyrVet, Inc.
Jul. 01, 2013
SyrVet, Inc.
Jul. 01, 2013
SyrVet, Inc.
Trademarks
Oct. 01, 2012
Macleod Pharmaceuticals
Oct. 31, 2013
Macleod Pharmaceuticals
Oct. 01, 2012
Macleod Pharmaceuticals
Jan. 02, 2013
Scidera Genomics, LLC
Jan. 02, 2013
Scidera Genomics, LLC
Nov. 01, 2013
Prima Tech Incorporated
Nov. 01, 2013
Prima Tech Incorporated
Nov. 01, 2013
Prima Tech Incorporated
Minimum
Nov. 01, 2013
Prima Tech Incorporated
Maximum
Nov. 01, 2013
Prima Tech Incorporated
Trademarks
Jan. 02, 2014
Chem Tech Ltd
Jan. 02, 2014
Chem Tech Ltd
Jan. 02, 2014
Chem Tech Ltd
Trademarks
May 01, 2012
Merial Limited.
May 31, 2013
Merial Limited.
May 01, 2012
Merial Limited.
Jun. 21, 2011
VeroMara
Jun. 21, 2011
VeroMara
Business Acquisition [Line Items]                                              
Cash consideration for purchase of business     $ 10,012,000     $ 9,918,000     $ 3,400,000   $ 12,068,000         $ 17,185,000     $ 3,200,000     $ 813,000  
Contingent consideration potential payment       1,500,000       100,000       600,000         1,000,000           200,000
Purchase price allocation for current assets                   35,000                     110,000    
Purchase price allocation for property and equipment       556,000       300,000   246,000   1,653,000         682,000       340,000    
Allocation of purchase price for contingent consideration potential payment       930,000       100,000       146,000         400,000       600,000    
Purchase price allocation for intangible assets       4,810,000       5,542,000   1,570,000   4,400,000         7,536,000       2,036,000    
Cash paid for data                                         500,000    
Reversed the remaining contingent consideration accrual to other income             38,000                         100,000      
Purchase price allocation for accounts receivable       747,000       353,000       963,000         380,000            
Purchase price allocation for inventory       2,195,000       1,238,000       2,796,000         4,096,000            
Purchase price allocation for current liabilities       226,000       82,000       1,840,000         184,000            
Purchase price allocation for deferred tax liabilities, current               2,054,000                              
Cash paid for contingent consideration             62,000                                
Purchase price allocation for non-amortizable trademarks         790,000                   1,500,000     662,000          
Finite lived intangible assets, useful life 5 years 20 years 15 years                   5 years 15 years   15 years              
Purchase price allocation for prepaid assets                       $ 8,000         $ 225,000